VACCINATION OF PATIENTS WITH ONCOLOGY DISEASES AGAINST MEASLES AND MUMPS
Abstract. One hundred and seven children (45 girls and 62 boys) in the age of 20 months — 14 years old (mean 9,62±0,37) suffered from acute lymphoblast leukosis and solid tumors in history have been examined in the clinic of Research Institute of children infections of FMBA. The vaccination history...
Guardado en:
Autores principales: | S. M. Kharit, T. V. Cherniaeva, E. V. Cherniaeva, N. K. Brusov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9ff6f23936f444a6b7d8dddb8ef11b26 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
por: Gupta Riya, et al.
Publicado: (2021) -
COMPARISON OF THE PRIMARY AND SECONDARY HUMORAL IMMUNE RESPONSE TO VACCINATION BY “PRIORIX”
por: A. P. Toptygina, et al.
Publicado: (2014) -
THE INFLUENCE OF DOUBLE IMMUNIZATION ON MORBIDITY OF MEASLES, MUMPS AND RUBELLA IN THE NORTH-WEST REGION OF RUSSIA
por: L. V. Lyalina, et al.
Publicado: (2014) -
Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection
por: Sara Mercader, et al.
Publicado: (2018) -
MODERN STATUS OF VACCINE PROPHYLAXIS OF MUMPS
por: E. O. Kontarova, et al.
Publicado: (2014)